USD 0.0
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2015 | 145 Thousand USD | -63.75% |
2014 | 400 Thousand USD | -12.85% |
2013 | 459 Thousand USD | 2.68% |
2012 | 447 Thousand USD | 110.85% |
2011 | 212 Thousand USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2022 FY | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2015 FY | 145 Thousand USD | -63.75% |
2015 Q1 | 280 Thousand USD | -30.0% |
2015 Q2 | 300 Thousand USD | 7.14% |
2015 Q3 | 223 Thousand USD | -25.67% |
2015 Q4 | 145 Thousand USD | -34.98% |
2014 Q2 | 554 Thousand USD | 48.53% |
2014 Q3 | 358 Thousand USD | -35.38% |
2014 Q4 | 400 Thousand USD | 11.73% |
2014 FY | 400 Thousand USD | -12.85% |
2014 Q1 | 373 Thousand USD | -18.74% |
2013 Q2 | 269 Thousand USD | -34.39% |
2013 FY | 459 Thousand USD | 2.68% |
2013 Q4 | 459 Thousand USD | 11.68% |
2013 Q3 | 411 Thousand USD | 52.79% |
2013 Q1 | 410 Thousand USD | -8.28% |
2012 Q4 | 447 Thousand USD | -1.11% |
2012 FY | 447 Thousand USD | 110.85% |
2012 Q1 | 528 Thousand USD | 149.06% |
2012 Q3 | 452 Thousand USD | 46.75% |
2012 Q2 | 308 Thousand USD | -41.67% |
2011 FY | 212 Thousand USD | 0.0% |
2011 Q4 | 212 Thousand USD | -35.76% |
2011 Q3 | 330 Thousand USD | 41.03% |
2011 Q2 | 234 Thousand USD | 377.55% |
2011 Q1 | 49 Thousand USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2004 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
American Medical Technologies Inc. | 133.82 Thousand USD | 100.0% |
Ansell Limited | 457.04 Million USD | 100.0% |
Ansell Limited | 457.9 Million USD | 100.0% |
Biotage AB (publ) | 43.33 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | 27.89 Thousand USD | 100.0% |
Psykey, Inc. | 49.94 Thousand USD | 100.0% |
ConvaTec Group Plc | 395.54 Million USD | 100.0% |
ConvaTec Group Plc | 396.1 Million USD | 100.0% |
Encision Inc. | 1.4 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | -9294.00 USD | 100.0% |
LifePoint, Inc. | 2.3 Million USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 441 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | 91.88 Thousand USD | 100.0% |
Reflect Scientific, Inc. | 972.29 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 49.87 Million USD | 100.0% |
Sector 10, Inc. | - USD | NaN% |
Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 100.0% |
SheerVision, Inc. | 339.66 Thousand USD | 100.0% |
United Health Products, Inc. | 33.59 Thousand USD | 100.0% |
Vasamed, Inc. | 449.02 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 8555.00 USD | 100.0% |
Yubo International Biotech Limited | 322.17 Thousand USD | 100.0% |